Stay updated on Dupilumab in Pediatric Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Pediatric Asthma Clinical Trial page.

Latest updates to the Dupilumab in Pediatric Asthma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a PubMed auto-fill note and a Revision: v3.3.2 tag. Removed the older PubMed publication attribution language and the Revision: v3.2.0 tag.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding status notice was removed from the page, while core study information remains unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedNo significant differences in the Study Details page between the screenshots; all sections such as objective, design, eligibility criteria, and locations appear unchanged, with only minor formatting variations. The page’s core information remains the same.SummaryDifference0.2%

- Check49 days agoChange DetectedAdded Cali, Colombia, 760043 as a study site and removed Santiago de Cali, Colombia, 760043.SummaryDifference0.0%

- Check71 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference0.8%

- Check78 days agoChange DetectedUpdated version to v3.1.0 and removed several drug-safety topic items (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while retaining an older revision in deletions; indicates content reorganization with emphasis on versioning.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Pediatric Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Asthma Clinical Trial page.